This Solicitation opportunity from Government of Canada was posted on January 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
ACAN 2nd Generation Smallpox Vaccine
Closed
WS5427643112CanadaSubmission Closed
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
General Info
Agency
Government of Canada → Department of Public Works and Government ServicesView Agency
NAICS
N/A
Place of Performance
*National Capital Region (NCR), CANSet-Aside
NONE
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
PhaseClosed
Submission Closed
Organization & Contact Information
Show more
AgencyGovernment of Canada → Department of Public Works and Government Services
Contacts1 person available
OfficeN/A
Organization / Agency
Government of Canada → Department of Public Works and Government Services
View Agency ProfileOffice AddressN/A
Contacts
Full Description
Show more
Advanced Contract Award Notice - 2nd Generation Smallpox Vaccine
An ACAN is a public notice indicating to the supplier community that a department or agency intends to award a contract for goods, services or construction to a pre-identified supplier, thereby allowing other suppliers to signal their interest in bidding, by submitting a statement of capabilities. If no supplier submits a statement of capabilities that meets the requirements set out in the ACAN, on or before the closing date stated in the ACAN, the contracting officer may then proceed with the award to the pre identified supplier.
Purpose of this ACAN: Public Services and Procurement Canada proposes to negotiate a contract with Emergent Product Development Gaithersburg Inc. on behalf of the Public Health Agency of Canada (PHAC) for the purchase of the vaccine ACAM2000®.
Limited Tendering Reason: In accordance with Government Contract Regulations (GCRs Part 1 - Conditions of Contract Entry - Bids - 6.(d)) Emergent Product Development Gaithersburg Inc., is the only known supplier of a live replicating vaccinia virus smallpox vaccine approved by Health Canada for the treatment of human smallpox disease.